false Q3 --01-31 2025 0001710495 P1Y 0001710495 2024-02-01 2024-10-31 0001710495 2025-01-21 0001710495 2024-10-31 0001710495 2024-01-31 0001710495 us-gaap:RelatedPartyMember 2024-10-31 0001710495 us-gaap:RelatedPartyMember 2024-01-31 0001710495 2024-08-01 2024-10-31 0001710495 2023-08-01 2023-10-31 0001710495 2023-02-01 2023-10-31 0001710495 us-gaap:CommonStockMember 2023-01-31 0001710495 us-gaap:AdditionalPaidInCapitalMember 2023-01-31 0001710495 us-gaap:RetainedEarningsMember 2023-01-31 0001710495 2023-01-31 0001710495 us-gaap:CommonStockMember 2024-01-31 0001710495 us-gaap:AdditionalPaidInCapitalMember 2024-01-31 0001710495 us-gaap:RetainedEarningsMember 2024-01-31 0001710495 us-gaap:CommonStockMember 2023-02-01 2023-10-31 0001710495 us-gaap:AdditionalPaidInCapitalMember 2023-02-01 2023-10-31 0001710495 us-gaap:RetainedEarningsMember 2023-02-01 2023-10-31 0001710495 us-gaap:CommonStockMember 2024-02-01 2024-10-31 0001710495 us-gaap:AdditionalPaidInCapitalMember 2024-02-01 2024-10-31 0001710495 us-gaap:RetainedEarningsMember 2024-02-01 2024-10-31 0001710495 us-gaap:CommonStockMember 2023-10-31 0001710495 us-gaap:AdditionalPaidInCapitalMember 2023-10-31 0001710495 us-gaap:RetainedEarningsMember 2023-10-31 0001710495 2023-10-31 0001710495 us-gaap:CommonStockMember 2024-10-31 0001710495 us-gaap:AdditionalPaidInCapitalMember 2024-10-31 0001710495 us-gaap:RetainedEarningsMember 2024-10-31 0001710495 PNXP:PineappleConsolidatedIncMember 2024-10-31 0001710495 PNXP:PNPLHoldingsIncMember us-gaap:SalesRevenueNetMember 2024-10-31 0001710495 PNXP:PNPLXPRESSXINCMember 2024-10-31 0001710495 PNXP:GoldstarIndustreesMember 2024-10-31 0001710495 PNXP:PNPLXPRESSIncMember 2024-10-31 0001710495 PNXP:PNPLXPRESSIIIncMember 2024-10-31 0001710495 PNXP:PineappleEquitiesIncMember 2024-10-31 0001710495 PNXP:FiveSixSixZeroWPicoAndHopeMember 2024-10-31 0001710495 PNXP:OneNineEightyFourOneVenturaAndHopeMember 2024-10-31 0001710495 PNXP:OneFourEightyFiveWSunsetAndHopeMember 2024-10-31 0001710495 2024-04-20 0001710495 2024-04-20 2024-04-20 0001710495 2024-08-09 0001710495 PNXP:EquipmentAndSoftwareMember srt:MinimumMember 2024-10-31 0001710495 PNXP:EquipmentAndSoftwareMember srt:MaximumMember 2024-10-31 0001710495 us-gaap:LeaseholdImprovementsMember 2024-10-31 0001710495 2024-04-30 0001710495 2024-02-01 2024-04-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended October 31, 2024

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to ___________

 

Commission File Number 001-41762

 

PINEAPPLE EXPRESS CANNABIS COMPANY

(Exact name of registrant as specified in its charter)

 

Nevada   36-4864568

(State or other jurisdiction

of incorporation or organization)

  

(I.R.S. Employer

Identification No.)

     
12301 Wilshire Blvd Ste 302, Los Angeles, CA 90025   90025
(Address of principal executive offices)   (Zip Code)

 

(888) 245-5703

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

As of January 21, 2025, there were 19,834,550 shares of common stock, par value $0.001, issued and outstanding.

 

 

 

 
 

 

Table of Contents

 

    Page
Part I—Financial Information 4
     
Item 1. Financial Statements 4
  Consolidated Balance Sheets at April 30, 2024 (Unaudited) and January 31, 2024 4
  Consolidated Statements of Operations for the Three Months Ended April 30, 2024 and 2023 (Unaudited) 5
  Consolidated Statements of Changes in Stockholders’ Equity for the Three Months Ended April 30, 2024 and 2023 (Unaudited) 6
  Consolidated Statements of Cash Flows for the Three Months Ended April 30, 2024 and 2023 (Unaudited) 7
  Notes to Unaudited Consolidated Financial Statements 8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 11
Item 3. Quantitative and Qualitative Disclosures About Market Risk 14
Item 4. Controls and Procedures 14
     
Part II—Other Information 14
     
Item 1. Legal Proceedings 14
Item 1A. Risk Factors 14
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 14
Item 3. Defaults Upon Senior Securities 15
Item 4. Mine Safety Disclosures 15
Item 5. Other Information 15
Item 6. Exhibits 15
     
  Signatures 16

 

2
 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report includes “forward-looking statements” within the meaning of the federal securities laws that involve risks and uncertainties. Forward-looking statements include statements we make concerning our plans, objectives, goals, strategies, future events, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this quarterly report, the words “estimates,” “expects,” “anticipates,” “projects,” “forecasts,” “plans,” “intends,” “believes,” “foresees,” “seeks,” “likely,” “may,” “might,” “will,” “should,” “goal,” “target” or “intends” and variations of these words or similar expressions (or the negative versions of any such words) are intended to identify forward-looking statements. All forward-looking statements are based upon information available to us on the date of this Quarterly Report.

 

These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. These risks and uncertainties are discussed in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended January 31, 2024, filed with the Securities and Exchange Commission on June 3, 2024, as the same may be updated from time to time.

 

All forward-looking statements attributable to us in this Quarterly Report apply only as of the date of this Quarterly Report and are expressly qualified in their entirety by the cautionary statements included in this Quarterly Report. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events, except as required by law.

 

3
 

 

PART I—FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

PINEAPPLE EXPRESS CANNABIS COMPANY AND SUBSIDIARIES

BALANCE SHEET

(Unaudited)

 

   October 31, 2024
(Unaudited)		   January 31, 2024
(Audited)		 
ASSETS          
Current Assets          
Cash and cash equivalents  $1000   $30 
Accounts Receivable   14204    - 
Total Current Assets   15204    30 
           
Other Assets          
Intangible Assets   3,000,000    - 
Due from related party   -    - 
Total Other Assets   3,000,000    - 
           
Fixed Assets          
Equipment, software, leasehold improvement, net   1495    1,840 
Total Fixed Assets   1495    1,840 
           
Total Assets  $3016699   $1,870 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Liabilities          
Current Liabilities          
Accounts Payable  $20484   $17,797 
Related party loan   2,967,714      
Deposit for stock purchase   -      
Total Current Liabilities   2988198   $17,797 
         - 
Total Liabilities  $2988198   $17,797 
           
Commitments and Contingencies   -    - 
           
Stockholders’ Equity (Deficit)          
Common stock, par value $0.001 per share; 75,000,000 shares authorized; 20,344,550 and 19,004,550 shares issued and outstanding, respectively   19834    20,745 
Additional paid-in capital   932,812    887,902 
Retained Earnings / (Accumulated Deficit)   (924,146)   (924,574)
Total Stockholders’ Equity (Deficit)   28501    (15,927)
           
Total Liabilities and Stockholders’ Equity (Deficit)  $3016699   $1,870 

 

See accompanying notes, which are an integral part of these financial statements.

 

4
 

 

PINEAPPLE EXPRESS CANNABIS COMPANY AND SUBSIDIARIES

STATEMENTS OF OPERATIONS

Three and Nine months ended October 31, 2024 and October 31, 2023

(Unaudited)

 

   2024   2023   2024   2023 
   For the Three Months Ended
October 31,		   For the Nine Months Ended
October 31,		 
   2024   2023   2024   2023 
                 
REVENUES   4332    -   $16168   $- 
Cost of goods sold   -    -    -    - 
Gross Profit   4332    -    16168      
                     
OPERATING EXPENSES                    
General and administrative expenses   (5580)   (2115)   (16740)   (51068)
TOTAL OPERATING EXPENSES   (5580)   (2115)   (16740)   (51068)
                     
Operating loss   (1248)   (2115)   (572)   (51068)
                     
Other Income                    
Income from equity-method investment   -         -    985737 
Total Other Income   -         -    985737 
                     
Income (loss) from operations before taxes   (1248)   (2115)   (572)   934669)
                     
PROVISION FOR INCOME TAXES   -    -         - 
                     
NET INCOME (LOSS)   (1248)   (2115)   (572)   934669 
                     
NET INCOME (LOSS) PER SHARE: BASIC AND DILUTED   (0.00)   (0.00)   (0.00)   (0.00)
                     
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED   19,836,217    20,344,550    19,836,217    20,344,550 

 

See accompanying notes, which are an integral part of these financial statements.

 

5
 

 

PINEAPPLE EXPRESS CANNABIS COMPANY AND SUBSIDIARIES

STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

Three and nine months ended October 31, 2024 and 2023

(Unaudited)

 

    Shares    Amount    Capital    Deficit)    (Deficit) 
    Common Stock    Additional Paid-in    Retained Earnings (Accumulated    Total
Stockholders’ Equity		 
    Shares    Amount    Capital    Deficit)    (Deficit) 
                          
Balance, January 31, 2023   19,004,550   $19,005   $19,641   $(582,996)  $(544,350)
                          
Issuance of common stock   1340000    1340    668661    -    670001 
Net loss for the nine months ended October 31, 2023   -    -    -    934669    934669 
                          
Balance, October 31, 2023   20,344,550    20,345    688,302    351673    1060320 
                          
Balance, January 31, 2024   20,744,550   $20,745   $887,902   $(924,574)  $(15,927)
                          
Issuance of common stock   90,000   $90   $44,910    -   $45,000 
                          
Cancellation of common stock   (1,000,000)  $(1,000)   -    1,000    - 
                          
Net income for the Nine months ended October 31, 2024   -    -    -    (572)   (572)
                          
Balance, October 31, 2024   -    19,835    932,812    924146    28501 

 

See accompanying notes, which are an integral part of these financial statements

 

6
 

 

PINEAPPLE EXPRESS CANNABIS COMPANY AND SUBSIDIARIES

STATEMENTS OF CASH FLOWS

Nine months ended October 31, 2024 and 2023

(Unaudited)

 

   Nine Months
Ended
October 31, 2024		   Nine Months
Ended
October 31, 2023		 
CASH FLOWS FROM OPERATING ACTIVITIES          
Net income (loss)  $(572)  $934669 
Adjustments to reconcile net income (loss) to net cash from operating activities:          
Depreciation   345    345 
Change in Accounts Receivable   (14204)   - 
Change in accounts payable   2668    14365
Income from equity-method investment   -    (985737)
CASH FLOWS FROM OPERATING ACTIVITIES   (11763)   (36358)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Related party loan   12144    36358 
           
CASH FLOWS FROM FINANCING ACTIVITIES   12144    36358 
           
NET CHANGE IN CASH   381    - 
           
Cash, beginning of period   30    - 
           
Cash, end of period   1000   $- 
           
SUPPLEMENTAL CASH FLOW INFORMATION:          
Interest paid  $-   $- 
Income taxes paid  $-   $- 

 

See accompanying notes, which are an integral part of these financial statements.

 

7
 

 

PINEAPPLE EXPRESS CANNABIS COMPANY AND SUBSIDIARIES

(f/k/a Minaro Corp.)

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2024

 

Note 1 – ORGANIZATION AND NATURE OF BUSINESS

 

Pineapple Express Cannabis Company is based in Los Angeles, California. The Company’s wholly owned operating subsidiary, Ananas Growth Ventures, serves as an incubator, helping early-stage ventures and startups in the cannabis sector through funding, mentoring, and training. The Company is also engaged in legal cannabis retail through its 50% owned equity method investee, Pineapple Consolidated Inc. (“PCI”). PCI runs Pineapple Express, a cannabis retailer and owns and manages retail cannabis ventures. PCI seeks to become a leading portfolio management company in the U.S. cannabis industry. With its headquarters in Los Angeles, Pineapple Express is rapidly increasing its footprint throughout California and is looking to scale into underdeveloped markets.

 

PCI has executed management contracts for 10% revenue sharing with eight entities in which it holds an equity interest through its wholly owned subsidiary, PNPL Holdings, Inc. Those entities are shown below:

 

  ● PNPLXpress X, Inc. (“Van Nuys Dispensary”): 10% as of October 31, 2024 (dispensary and delivery).
     
  ● Goldstar Industrees (“Northridge Dispensary”): 29% as of October 31, 2024 (dispensary and delivery).
     
  ● PNPLXpress, Inc. (“Hollywood Dispensary”): 10% equity interest as of October 31, 2024 (dispensary and delivery).
     
  ● PNPLXpress II, Inc. (“Northeast LA Dispensary”): 49% interest as of October 31, 2024 (dispensary and delivery).
     
  ● Pineapple Equities, Inc. (“Beverly Grove Dispensary”): 24% equity interest as of October 31, 2024 (dispensary and delivery).
     
  ● 5660 W. Pico & Hope (Mid-Wilshire Dispensary): 49% equity interest as of October 31, 2024 (dispensary and delivery).
     
  ● 19841 Ventura & Hope (Woodland Hills Dispensary): 19% equity interest as of October 31, 2024 (dispensary and delivery).
     
  ● 1485 W. Sunset & Hope (Echo Park Dispensary): 29% equity interest as of October 31, 2024 (dispensary and delivery).

 

Effective April 20th, 2024, the Company executed a revenue share agreement with PCI whereas the Company will receive half of the 10% management fee at the locations listed above in exchange for a promissory note of $5,000,000, bearing one percent (1%) interest per year, and payable at the Company’s discretion with a maturity date of April 20, 2029. The note was later reduced by $2,000,000 by mutual agreement on August 9, 2024.

 

Note 2 – GOING CONCERN

 

The accompanying unaudited financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”), which contemplate continuation of the Company as a going concern. Minimal Cash, and accumulated deficit of $924,146 raises substantial doubt about the Company’s ability to continue as a going concern. Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses. The Company intends to position itself so that it will be able to raise additional funds through the capital markets. There are no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern.

 

Note 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation

 

The accompanying financial statements have been prepared in accordance with GAAP. The Company’s year-end is January 31.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

8
 

 

PINEAPPLE EXPRESS CANNABIS COMPANY AND SUBSIDIARIES

(f/k/a Minaro Corp.)

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2024

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.

 

Income Taxes

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.

 

Equipment

 

Equipment is stated at cost, net of accumulated depreciation. The cost of equipment and software is depreciated using the straight-line method over one and five years and the cost of leasehold improvement is depreciated using the straight-line method over one year. Expenditures for maintenance and repairs are charged to expense as incurred. Additions, major renewals and replacements that increase the equipment’s useful life are capitalized. Equipment sold or retired, together with the related accumulated depreciation, is removed from the appropriate accounts and the resultant gain or loss is included in net income.

 

Basic Income (Loss) Per Share

 

The Company computes income (loss) per share in accordance with the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Codification (“ASC”) 260 “Earnings per Share”. Basic income (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. For the three months ended October 31, 2024, there were no potentially dilutive debt or equity instruments issued or outstanding.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC 606, “Revenue from Contracts with Customers”. ASC 606 was adopted on February 1, 2018. The core principle of ASC 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. An entity recognizes revenue in accordance with that core principle by applying the following steps: Step 1: Identify the contract(s) with a customer Step 2: Identify the performance obligations in the contract Step 3: Determine the transaction price Step 4: Allocate the transaction price to the performance obligations in the contract Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation. Specifically, Section 606-10-50 requires an entity to provide information about: (a) revenue recognized from contracts with customers, including the disaggregation of revenue into appropriate categories; (b) contract balances, including the opening and closing balances of receivables, contract assets, and contract liabilities; (c) performance obligations, including when the entity typically satisfies its performance obligations and the transaction price that is allocated to the remaining performance obligations in a contract; and (d) significant judgments, and changes in judgments, made in applying the requirements to those contracts. For the three months ended October 31, 2024, the Company did not generate any revenues.

 

Recent Accounting Pronouncements

 

We have reviewed all the recently issued, but not yet effective, accounting pronouncements and we do not believe any of these pronouncements will have a material impact on the Company.

 

9
 

 

PINEAPPLE EXPRESS CANNABIS COMPANY AND SUBSIDIARIES

(f/k/a Minaro Corp.)

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2024

 

Impact of COVID-19 on the Company

 

The global outbreak of COVID-19 has led to severe disruptions in general economic activities, as businesses and governments have taken broad actions to mitigate this public health crisis. Although the Company has not experienced any significant disruption to its business to date, these conditions could significantly negatively impact the Company’s business in the future.

 

The extent to which the COVID-19 outbreak ultimately impacts the Company’s business, future revenues, results of operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to, the duration and spread of the outbreak, its severity and longevity, the actions to curtail the virus and treat its impact (including an effective vaccine), and how quickly and to what extent normal economic and operating conditions can resume. Even after the COVID-19 outbreak has subsided, the Company may be at risk of experiencing a significant impact to its business as a result of the global economic impact, including any economic downturn or recession that has occurred or may occur in the future.

 

As a result of the impact of COVID-19 on capital markets, the availability, amount, and type of financing available to the Company in the near future is uncertain and cannot be assured and is largely dependent upon evolving market conditions and other factors.

 

The Company intends to continue to monitor the situation and may adjust its current business plans as more information and guidance become available.

 

Note 4 – RELATED PARTY TRANSACTIONS

 

The Company owes $2,966,714 to its related party equity method investee, Pineapple Consolidated, Inc. (“PCI”), as of April 30, 2024. Bearing one percent (1%) interest per year, and payable at the Company’s discretion with a maturity date of April 20, 2029.

 

The Lenders have agreed to pay an aggregate of Five Million U.S. Dollars ($5,000,000) to PCI within five (5) years of the effective date of this Agreement in exchange for revenue generated at seven (7) retail dispensaries in Los Angeles, California. That obligation was later reduced to $3,000,000 by mutual agreement.

 

Note 5 – COMMITMENTS AND CONTINGENCIES

 

The Company currently subleases from PCI office space at 12301 Wilshire Blvd. #302, Los Angeles, CA 90025, at no charge.

 

From time-to-time, the Company is subject to various litigation and other claims in the normal course of business. The Company establishes liabilities in connection with legal actions that management deems to be probable and estimable. No amounts have been accrued in the financial statements with respect to any matters.

 

Note 6 – SUBSEQUENT EVENTS

 

In accordance with ASC 855, “Subsequent Events”, the Company has analyzed its operations subsequent to October 31, 2024, through January 18, 2025, and has determined that it does not have any material subsequent events to disclose in these unaudited financial statements.

 

10
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis of the financial condition and results of operations of Pineapple Express Cannabis Company (f/k/a Minaro Corp.) and its subsidiaries (together, the “Company” or “Pineapple Express Cannabis”) should be read in conjunction with our unaudited consolidated financial statements and the accompanying notes thereto included elsewhere in this Quarterly Report on Form 10-Q. References in this Management’s Discussion and Analysis of Financial Condition and Results of Operations to “us,” “we,” “our,” and similar terms refer to the Company. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those set forth under the Risk Factors section of our Annual Report on Form 10-K for the year ended January 31, 2023, filed with the Securities and Exchange Commission (the “SEC”) on May 24, 2023, as the same may be updated from time to time. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements.

 

Overview

 

We are based in Los Angeles, California. Our wholly owned operating subsidiary, Ananas Growth Ventures, serves as an incubator, helping early-stage ventures and startups in the cannabis sector through funding, mentoring, and training. We are also engaged in legal cannabis retail through our 50% owned equity method investee, Pineapple Consolidated Inc. (“PCI”). PCI runs Pineapple Express, a cannabis retailer, and owns and manages retail cannabis ventures. PCI seeks to become a leading portfolio management company in the U.S. cannabis industry. With its headquarters in Los Angeles, Pineapple Express is rapidly increasing its footprint throughout California and is looking to scale into underdeveloped markets.

 

PCI has executed management contracts for 10% revenue sharing with eight entities in which it holds an equity interest through its wholly owned subsidiary, PNPL Holdings, Inc. Those entities are shown below:

 

  ● PNPLXpress X, Inc. (“Van Nuys Dispensary”): 10% as of October 31, 2024 (dispensary and delivery).
  ● Goldstar Industrees (“Northridge Dispensary”): 29% as of October 31, 2024 (dispensary and delivery).
  ● PNPLXpress, Inc. (“Hollywood Dispensary”): 10% equity interest as of October 31, 2024 (dispensary and delivery).
  ● PNPLXpress II, Inc (“Northeast LA Dispensary”): 49% interest as of October 31, 2024 (dispensary and delivery).
  ● Pineapple Equities, Inc (“Beverly Grove Dispensary”): 24% equity interest as of October 31, 2024 (dispensary and delivery).
  ● 5660 W. Pico & Hope (Mid-Wilshire Dispensary): 49% equity interest as of October 31, 2024 (dispensary and delivery).
  ● 1485 W. Sunset & Hope (Echo Park Dispensary): 29% equity interest as of October 31, 2024 (dispensary and delivery).
  ● Pineapple Venice, Inc. (Venice Dispensary): 49% equity interest as of October 31, 2024 (dispensary and delivery).

 

Recent Developments

 

On December 18, 2022, we entered into a Share Exchange Agreement (the “Exchange Agreement”) with Yulia Lazaridou, our then-majority stockholder, PCI, and the PCI stockholders (collectively, the “PCI Stockholders”). Pursuant to the terms of the Exchange Agreement, the PCI Stockholders exchanged an aggregate of 50,000 shares of PCI common stock, representing 50% of the outstanding PCI common stock, for 18,000,000 shares of our common stock.

 

In addition, on December 18, 2022, in a transaction related to and a condition to the Exchange, Ms. Lazaridou and the Company entered into that certain Resignation, Separation and Release Agreement (the “Resignation Agreement”), pursuant to which (i) we redeemed 2,800,000 shares of Company common stock owned by Ms. Lazaridou (the “Lazaridou Shares”) in exchange for a payment by us of $540,904; and (b) Ms. Lazaridou resigned as our sole director and officer, effective as of December 21, 2022.

 

11
 

 

In order to fund the payment for the Lazaridou Shares, contemporaneous with the Exchange, on December 18, 2022, PCI loaned $540,904 to us. The loan (the “PCI Loan”) matures on June 30, 2023 and earns interest at an annual rate of 1%.

 

In addition, on December 18, 2022, Ms. Lazaridou, as sole director and majority stockholder, (i) elected Matthew Feinstein as sole director of the Company; (ii) appointed Mr. Feinstein as Chief Executive Officer, President, Chairman of the Board and Interim Chief Financial Officer of the Company; (iii) accepted Ms. Lazaridou’s resignation; (iv) approved the Exchange Agreement; and (v) approved the Resignation Agreement.

 

As a result of the above-described transactions, the Company is 50% owned by the PCI Stockholders and PCI is 50% owned by the Company.

 

On December 30, 2022, we notified Financial Industry Regulatory Authority (“FINRA”) of our intent to change our corporate name from “Minaro Corp.” to “Pineapple Express Cannabis Company” and to change our trading symbol. These corporate actions are subject to FINRA review and clearance.

 

On January 5, 2023, the Company filed Restated Articles of Incorporation with the State of Nevada following approval of the sole director and majority shareholder (“Restated Articles”). The Restated Articles (i) changed the name of the Company to Pineapple Express Cannabis Company, (ii) added an additional authorized class of capital stock, namely ten million (10,000,000) shares of Preferred Stock, in addition to the previously authorized seventy-five million (75,000,000) shares of Common Stock. As a result, the name of the Company now has been changed to Pineapple Express Cannabis Company.

 

On December 30, 2022 the Company applied to the Financial Industry Regulatory Authority (“FINRA”) for approval with respect to the change of the Company’s name in the Restated Articles. The Company separately applied to FINRA to change the Company’s stock ticker trading symbol. These two corporate actions were subject to FINRA review and clearance which was received during the prior reporting period.

 

Results of Operations

 

Three Months Ended October 31, 2024 Compared to Three Months Ended October 31, 2023

 

Revenues

 

For the three months ended October 31, 2024 and 2023, the Company generated revenues of $4,332 and $0, respectively. The increase was primarily due to the Company’s management fee revenue during the quarter.

 

Cost of Goods Sold

 

For the three months ended October 31, 2024 and 2023, the cost of goods sold was $0 and $0, respectively.

 

Total Operating Expenses

 

Total operating expenses for the three months ended October 31, 2024 and 2023 were $5,580 and $19,247, respectively. The increase was primarily due to an increase in legal fees and audit fees, partly due to the sale of the Company and the acquisition of PCI by the Company. Operating expenses for the three months ended October 31, 2024 consisted of bank charges; depreciation expense and professional fees. Operating expenses for the three months ended October 31, 2023 consisted of bank charges; depreciation expense; legal fees; audit fees; consulting fees; and professional fees.

 

12
 

 

Net Income (Loss)

 

Net income (loss) for the three months ended October 31, 2024 and 2023 was ($1,248) and ($2,115) respectively.

 

Liquidity and Capital Resources

 

As of October 31, 2024, the Company had cash of $1043 and an accumulated deficit of 919,554. To date, we have financed our operations primarily through the issuance of debt and equity sourced capital.

 

The following table sets forth a summary of our cash flows for the three months ended October 31, 2024 and 2023:

 

   Three Months Ended October 31, 
   2024   2023 
Net cash used in operating activities  $-   $(11,697)
Net cash provided by investing activities        - 
Net cash provided by financing activities   -    11,697 
Net decrease in cash   -      
Cash, beginning of period   30      
Cash, end of period  $1043   $  

 

Since inception, we have financed our cash flow requirements primarily through issuance of common stock and debt financing. As we expand our activities, we may continue to experience net negative cash flows from operations. We anticipate obtaining additional financing to fund operations through additional common stock offerings, to the extent available, or to obtain additional financing to the extent necessary to augment our working capital. There can be no assurance that we will be able to obtain financing on commercially acceptable terms, if at all.

 

We anticipate that we will incur operating losses in the next 12 months. Our lack of operating history makes predictions of future operating results difficult to ascertain. Our prospects must be considered in light of the risks, expenses and difficulties frequently encountered by companies in their early stage of development, particularly companies in new and rapidly evolving markets. There can be no assurance that we will be successful in addressing such risks, and the failure to do so can have a material adverse effect.

 

Critical Accounting Policies and Estimates

 

Our management’s discussion and analysis of our financial condition and results of operations is based on our unaudited consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The preparation of our unaudited consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reported period. In accordance with GAAP, we base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

 

13
 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

A smaller reporting company is not required to provide the information required by this Item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Principal Financial Officer, to allow timely decisions regarding required disclosure.

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Principal Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of April 30, 2023. Based upon his evaluation, our Chief Executive Officer and Principal Financial Officer concluded that, as of April 30, 2023, our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were not effective.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Changes in Internal Control over Financial Reporting

 

During the three months ended April 30, 2024, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

PART II—OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, we are involved in ordinary routine litigation typical for companies engaged in our line of business. As of the date of this Quarterly Report on Form 10-Q, there are no pending legal proceedings to which the Company is a party or in which any director, officer or affiliate of the Company, any owner of record or beneficially of more than 5% of any class of voting securities of the Company, or security holder is a party adverse to the Company or has a material interest adverse to the Company that we believe would be likely, individually or in the aggregate, to have a material adverse effect on our financial condition or results of operations.

 

ITEM 1A. RISK FACTORS

 

Smaller reporting companies are not required to provide disclosure pursuant to this Item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

During the three months ended July 31, 2024, the Company issued unregistered equity securities as follows:

 

None.

 

The above securities issuances (if any) were exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on the exemptions provided by Regulation D and Section 4(a)(2), as applicable under the Securities Act.

 

14
 

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

(a) None.

 

(b) There have been no material changes to the procedures by which security holders may recommend nominees to our Board of Directors since we last provided disclosure in response to the requirements of Item 407(c)(3) of Regulation S-K promulgated under the Exchange Act.

 

ITEM 6. EXHIBITS

 

Exhibit No.   Description
     
31.1*   Certification of Chief Executive Officer pursuant to Exchange Act Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*   Certification of Principal Financial Officer pursuant to Exchange Act Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**   Certification by the Chief Executive Officer and principal financial officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*   Inline XBRL Instance Document.
101.SCH*   Inline XBRL Taxonomy Extension Schema.
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase.
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase.
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase.
101.DEF*   Inline XBRL Taxonomy Extension Definition Document.
104*   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

* Filed herewith.
** Furnished herewith.

 

15
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  PINEAPPLE EXPRESS CANNABIS COMPANY
     
Date: January 21, 2025 By: /s/ Matthew Feinstein
  Name: Matthew Feinstein
  Title: Chief Executive Officer, President and Interim Chief Financial Officer (principal executive officer, principal financial officer and principal accounting officer)

 

16

 

 

 

Exhibit 31.1

 

CERTIFICATIONS

 

I, Matthew Feinstein, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended October 31, 2024 of Pineapple Express Cannabis Company;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: January 21, 2025

 

/s/ Matthew Feinstein  
Matthew Feinstein  
Chief Executive Officer, President and Interim Chief Financial Officer (principal executive officer)  

 

 

 

Exhibit 31.2

 

CERTIFICATIONS

 

I, Matthew Feinstein, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended October 31, 2024 of Pineapple Express Cannabis Company;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: January 21, 2025

 

/s/ Matthew Feinstein  
Matthew Feinstein  
Chief Executive Officer, President and Interim Chief Financial Officer (principal financial officer)  

 

 

 

Exhibit 32.1

 

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Pineapple Express Cannabis Company (the “Company”) for the quarterly period ended October 31, 2024 as filed with the Securities and Exchange Commission (the “Report”), I, Matthew Feinstein, Chief Executive Officer, President and Interim Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: January 21, 2025 /s/ Matthew Feinstein
  Matthew Feinstein
  Chief Executive Officer, President and Interim Chief Financial Officer (principal executive officer and principal financial officer)

 

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

 

 

v3.24.4
Cover - $ / shares
 9 Months Ended
Oct. 31, 2024
Jan. 21, 2025
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Oct. 31, 2024  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2025  
Current Fiscal Year End Date --01-31  
Entity File Number 001-41762  
Entity Registrant Name PINEAPPLE EXPRESS CANNABIS COMPANY  
Entity Central Index Key 0001710495  
Entity Tax Identification Number 36-4864568  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 12301 Wilshire Blvd Ste 302  
Entity Address, City or Town Los Angeles  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 90025  
City Area Code (888)  
Local Phone Number 245-5703  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   19,834,550
Entity Listing, Par Value Per Share $ 0.001  
v3.24.4
Balance Sheet (Unaudited) - USD ($)
Oct. 31, 2024
Jan. 31, 2024
Current Assets    
Cash and cash equivalents $ 1,000 $ 30
Accounts Receivable 14,204
Total Current Assets 15,204 30
Other Assets    
Intangible Assets 3,000,000
Total Other Assets 3,000,000
Fixed Assets    
Equipment, software, leasehold improvement, net 1,495 1,840
Total Fixed Assets 1,495 1,840
Total Assets 3,016,699 1,870
Current Liabilities    
Accounts Payable 20,484 17,797
Related party loan 2,967,714  
Deposit for stock purchase  
Total Current Liabilities 2,988,198 17,797
Total Liabilities 2,988,198 17,797
Commitments and Contingencies
Stockholders’ Equity (Deficit)    
Common stock, par value $0.001 per share; 75,000,000 shares authorized; 20,344,550 and 19,004,550 shares issued and outstanding, respectively 19,834 20,745
Additional paid-in capital 932,812 887,902
Retained Earnings / (Accumulated Deficit) (924,146) (924,574)
Total Stockholders’ Equity (Deficit) 28,501 (15,927)
Total Liabilities and Stockholders’ Equity (Deficit) 3,016,699 1,870
Related Party [Member]    
Other Assets    
Due from related party
v3.24.4
Balance Sheet (Unaudited) (Parenthetical) - $ / shares
Oct. 31, 2024
Jan. 31, 2024
Statement of Financial Position [Abstract]    
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 75,000,000 75,000,000
Common stock, shares issued 20,344,550 19,004,550
Common stock, shares outstanding 20,344,550 19,004,550
v3.24.4
Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Income Statement [Abstract]        
REVENUES $ 4,332 $ 16,168
Cost of goods sold
Gross Profit 4,332 16,168  
OPERATING EXPENSES        
General and administrative expenses (5,580) (2,115) (16,740) (51,068)
TOTAL OPERATING EXPENSES (5,580) (2,115) (16,740) (51,068)
Operating loss (1,248) (2,115) (572) (51,068)
Other Income        
Income from equity-method investment   985,737
Total Other Income   985,737
Income (loss) from operations before taxes (1,248) (2,115) (572) 934,669
PROVISION FOR INCOME TAXES  
NET INCOME (LOSS) $ (1,248) $ (2,115) $ (572) $ 934,669
NET INCOME (LOSS) PER SHARE: BASIC $ (0.00) $ (0.00) $ (0.00) $ (0.00)
NET INCOME (LOSS) PER SHARE: DILUTED $ (0.00) $ (0.00) $ (0.00) $ (0.00)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC 19,836,217 20,344,550 19,836,217 20,344,550
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: DILUTED 19,836,217 20,344,550 19,836,217 20,344,550
v3.24.4
Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Jan. 31, 2023 $ 19,005 $ 19,641 $ (582,996) $ (544,350)
Balance shares at Jan. 31, 2023 19,004,550      
Issuance of common stock $ 1,340 668,661 670,001
Issuance of common stock, shares 1,340,000      
Net income loss 934,669 934,669
Balance at Oct. 31, 2023 $ 20,345 688,302 351,673 1,060,320
Balance shares at Oct. 31, 2023 20,344,550      
Balance at Jan. 31, 2024 $ 20,745 887,902 (924,574) (15,927)
Balance shares at Jan. 31, 2024 20,744,550      
Issuance of common stock $ 90 44,910 45,000
Issuance of common stock, shares 90,000      
Net income loss (572) (572)
Cancellation of common stock $ (1,000) 1,000
Cancellation of common stock, shares (1,000,000)      
Balance at Oct. 31, 2024 $ 19,835 $ 932,812 $ 924,146 $ 28,501
Balance shares at Oct. 31, 2024      
v3.24.4
Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income (loss) $ (572) $ 934,669
Adjustments to reconcile net income (loss) to net cash from operating activities:    
Depreciation 345 345
Change in Accounts Receivable (14,204)
Change in accounts payable 2,668 14,365
Income from equity-method investment (985,737)
CASH FLOWS FROM OPERATING ACTIVITIES (11,763) (36,358)
CASH FLOWS FROM FINANCING ACTIVITIES    
Related party loan 12,144 36,358
CASH FLOWS FROM FINANCING ACTIVITIES 12,144 36,358
NET CHANGE IN CASH 381
Cash, beginning of period 30
Cash, end of period 1,000
SUPPLEMENTAL CASH FLOW INFORMATION:    
Interest paid
Income taxes paid
v3.24.4
ORGANIZATION AND NATURE OF BUSINESS
 9 Months Ended
Oct. 31, 2024
Accounting Policies [Abstract]  
ORGANIZATION AND NATURE OF BUSINESS

Note 1 – ORGANIZATION AND NATURE OF BUSINESS

 

Pineapple Express Cannabis Company is based in Los Angeles, California. The Company’s wholly owned operating subsidiary, Ananas Growth Ventures, serves as an incubator, helping early-stage ventures and startups in the cannabis sector through funding, mentoring, and training. The Company is also engaged in legal cannabis retail through its 50% owned equity method investee, Pineapple Consolidated Inc. (“PCI”). PCI runs Pineapple Express, a cannabis retailer and owns and manages retail cannabis ventures. PCI seeks to become a leading portfolio management company in the U.S. cannabis industry. With its headquarters in Los Angeles, Pineapple Express is rapidly increasing its footprint throughout California and is looking to scale into underdeveloped markets.

 

PCI has executed management contracts for 10% revenue sharing with eight entities in which it holds an equity interest through its wholly owned subsidiary, PNPL Holdings, Inc. Those entities are shown below:

 

  ● PNPLXpress X, Inc. (“Van Nuys Dispensary”): 10% as of October 31, 2024 (dispensary and delivery).
     
  ● Goldstar Industrees (“Northridge Dispensary”): 29% as of October 31, 2024 (dispensary and delivery).
     
  ● PNPLXpress, Inc. (“Hollywood Dispensary”): 10% equity interest as of October 31, 2024 (dispensary and delivery).
     
  ● PNPLXpress II, Inc. (“Northeast LA Dispensary”): 49% interest as of October 31, 2024 (dispensary and delivery).
     
  ● Pineapple Equities, Inc. (“Beverly Grove Dispensary”): 24% equity interest as of October 31, 2024 (dispensary and delivery).
     
  ● 5660 W. Pico & Hope (Mid-Wilshire Dispensary): 49% equity interest as of October 31, 2024 (dispensary and delivery).
     
  ● 19841 Ventura & Hope (Woodland Hills Dispensary): 19% equity interest as of October 31, 2024 (dispensary and delivery).
     
  ● 1485 W. Sunset & Hope (Echo Park Dispensary): 29% equity interest as of October 31, 2024 (dispensary and delivery).

 

Effective April 20th, 2024, the Company executed a revenue share agreement with PCI whereas the Company will receive half of the 10% management fee at the locations listed above in exchange for a promissory note of $5,000,000, bearing one percent (1%) interest per year, and payable at the Company’s discretion with a maturity date of April 20, 2029. The note was later reduced by $2,000,000 by mutual agreement on August 9, 2024.

 
v3.24.4
GOING CONCERN
 9 Months Ended
Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN

Note 2 – GOING CONCERN

 

The accompanying unaudited financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”), which contemplate continuation of the Company as a going concern. Minimal Cash, and accumulated deficit of $924,146 raises substantial doubt about the Company’s ability to continue as a going concern. Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses. The Company intends to position itself so that it will be able to raise additional funds through the capital markets. There are no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern.

 
v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 9 Months Ended
Oct. 31, 2024
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Note 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation

 

The accompanying financial statements have been prepared in accordance with GAAP. The Company’s year-end is January 31.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

 

PINEAPPLE EXPRESS CANNABIS COMPANY AND SUBSIDIARIES

(f/k/a Minaro Corp.)

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2024

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.

 

Income Taxes

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.

 

Equipment

 

Equipment is stated at cost, net of accumulated depreciation. The cost of equipment and software is depreciated using the straight-line method over one and five years and the cost of leasehold improvement is depreciated using the straight-line method over one year. Expenditures for maintenance and repairs are charged to expense as incurred. Additions, major renewals and replacements that increase the equipment’s useful life are capitalized. Equipment sold or retired, together with the related accumulated depreciation, is removed from the appropriate accounts and the resultant gain or loss is included in net income.

 

Basic Income (Loss) Per Share

 

The Company computes income (loss) per share in accordance with the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Codification (“ASC”) 260 “Earnings per Share”. Basic income (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. For the three months ended October 31, 2024, there were no potentially dilutive debt or equity instruments issued or outstanding.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC 606, “Revenue from Contracts with Customers”. ASC 606 was adopted on February 1, 2018. The core principle of ASC 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. An entity recognizes revenue in accordance with that core principle by applying the following steps: Step 1: Identify the contract(s) with a customer Step 2: Identify the performance obligations in the contract Step 3: Determine the transaction price Step 4: Allocate the transaction price to the performance obligations in the contract Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation. Specifically, Section 606-10-50 requires an entity to provide information about: (a) revenue recognized from contracts with customers, including the disaggregation of revenue into appropriate categories; (b) contract balances, including the opening and closing balances of receivables, contract assets, and contract liabilities; (c) performance obligations, including when the entity typically satisfies its performance obligations and the transaction price that is allocated to the remaining performance obligations in a contract; and (d) significant judgments, and changes in judgments, made in applying the requirements to those contracts. For the three months ended October 31, 2024, the Company did not generate any revenues.

 

Recent Accounting Pronouncements

 

We have reviewed all the recently issued, but not yet effective, accounting pronouncements and we do not believe any of these pronouncements will have a material impact on the Company.

 

 

PINEAPPLE EXPRESS CANNABIS COMPANY AND SUBSIDIARIES

(f/k/a Minaro Corp.)

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2024

 

Impact of COVID-19 on the Company

 

The global outbreak of COVID-19 has led to severe disruptions in general economic activities, as businesses and governments have taken broad actions to mitigate this public health crisis. Although the Company has not experienced any significant disruption to its business to date, these conditions could significantly negatively impact the Company’s business in the future.

 

The extent to which the COVID-19 outbreak ultimately impacts the Company’s business, future revenues, results of operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to, the duration and spread of the outbreak, its severity and longevity, the actions to curtail the virus and treat its impact (including an effective vaccine), and how quickly and to what extent normal economic and operating conditions can resume. Even after the COVID-19 outbreak has subsided, the Company may be at risk of experiencing a significant impact to its business as a result of the global economic impact, including any economic downturn or recession that has occurred or may occur in the future.

 

As a result of the impact of COVID-19 on capital markets, the availability, amount, and type of financing available to the Company in the near future is uncertain and cannot be assured and is largely dependent upon evolving market conditions and other factors.

 

The Company intends to continue to monitor the situation and may adjust its current business plans as more information and guidance become available.

 
v3.24.4
RELATED PARTY TRANSACTIONS
 9 Months Ended
Oct. 31, 2024
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

Note 4 – RELATED PARTY TRANSACTIONS

 

The Company owes $2,966,714 to its related party equity method investee, Pineapple Consolidated, Inc. (“PCI”), as of April 30, 2024. Bearing one percent (1%) interest per year, and payable at the Company’s discretion with a maturity date of April 20, 2029.

 

The Lenders have agreed to pay an aggregate of Five Million U.S. Dollars ($5,000,000) to PCI within five (5) years of the effective date of this Agreement in exchange for revenue generated at seven (7) retail dispensaries in Los Angeles, California. That obligation was later reduced to $3,000,000 by mutual agreement.

 
v3.24.4
COMMITMENTS AND CONTINGENCIES
 9 Months Ended
Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

Note 5 – COMMITMENTS AND CONTINGENCIES

 

The Company currently subleases from PCI office space at 12301 Wilshire Blvd. #302, Los Angeles, CA 90025, at no charge.

 

From time-to-time, the Company is subject to various litigation and other claims in the normal course of business. The Company establishes liabilities in connection with legal actions that management deems to be probable and estimable. No amounts have been accrued in the financial statements with respect to any matters.

 
v3.24.4
SUBSEQUENT EVENTS
 9 Months Ended
Oct. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

Note 6 – SUBSEQUENT EVENTS

 

In accordance with ASC 855, “Subsequent Events”, the Company has analyzed its operations subsequent to October 31, 2024, through January 18, 2025, and has determined that it does not have any material subsequent events to disclose in these unaudited financial statements.
v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 9 Months Ended
Oct. 31, 2024
Accounting Policies [Abstract]  
Basis of presentation

Basis of presentation

 

The accompanying financial statements have been prepared in accordance with GAAP. The Company’s year-end is January 31.

 
Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

 

PINEAPPLE EXPRESS CANNABIS COMPANY AND SUBSIDIARIES

(f/k/a Minaro Corp.)

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2024

 
Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.

 
Income Taxes

Income Taxes

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.

 
Equipment

Equipment

 

Equipment is stated at cost, net of accumulated depreciation. The cost of equipment and software is depreciated using the straight-line method over one and five years and the cost of leasehold improvement is depreciated using the straight-line method over one year. Expenditures for maintenance and repairs are charged to expense as incurred. Additions, major renewals and replacements that increase the equipment’s useful life are capitalized. Equipment sold or retired, together with the related accumulated depreciation, is removed from the appropriate accounts and the resultant gain or loss is included in net income.

 
Basic Income (Loss) Per Share

Basic Income (Loss) Per Share

 

The Company computes income (loss) per share in accordance with the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Codification (“ASC”) 260 “Earnings per Share”. Basic income (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. For the three months ended October 31, 2024, there were no potentially dilutive debt or equity instruments issued or outstanding.

 
Revenue Recognition

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC 606, “Revenue from Contracts with Customers”. ASC 606 was adopted on February 1, 2018. The core principle of ASC 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. An entity recognizes revenue in accordance with that core principle by applying the following steps: Step 1: Identify the contract(s) with a customer Step 2: Identify the performance obligations in the contract Step 3: Determine the transaction price Step 4: Allocate the transaction price to the performance obligations in the contract Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation. Specifically, Section 606-10-50 requires an entity to provide information about: (a) revenue recognized from contracts with customers, including the disaggregation of revenue into appropriate categories; (b) contract balances, including the opening and closing balances of receivables, contract assets, and contract liabilities; (c) performance obligations, including when the entity typically satisfies its performance obligations and the transaction price that is allocated to the remaining performance obligations in a contract; and (d) significant judgments, and changes in judgments, made in applying the requirements to those contracts. For the three months ended October 31, 2024, the Company did not generate any revenues.

 
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

We have reviewed all the recently issued, but not yet effective, accounting pronouncements and we do not believe any of these pronouncements will have a material impact on the Company.

 

 

PINEAPPLE EXPRESS CANNABIS COMPANY AND SUBSIDIARIES

(f/k/a Minaro Corp.)

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2024

 
Impact of COVID-19 on the Company

Impact of COVID-19 on the Company

 

The global outbreak of COVID-19 has led to severe disruptions in general economic activities, as businesses and governments have taken broad actions to mitigate this public health crisis. Although the Company has not experienced any significant disruption to its business to date, these conditions could significantly negatively impact the Company’s business in the future.

 

The extent to which the COVID-19 outbreak ultimately impacts the Company’s business, future revenues, results of operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to, the duration and spread of the outbreak, its severity and longevity, the actions to curtail the virus and treat its impact (including an effective vaccine), and how quickly and to what extent normal economic and operating conditions can resume. Even after the COVID-19 outbreak has subsided, the Company may be at risk of experiencing a significant impact to its business as a result of the global economic impact, including any economic downturn or recession that has occurred or may occur in the future.

 

As a result of the impact of COVID-19 on capital markets, the availability, amount, and type of financing available to the Company in the near future is uncertain and cannot be assured and is largely dependent upon evolving market conditions and other factors.

 

The Company intends to continue to monitor the situation and may adjust its current business plans as more information and guidance become available.
v3.24.4
ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) - USD ($)
 3 Months Ended
Apr. 20, 2024
Apr. 30, 2024
Oct. 31, 2024
Aug. 09, 2024
Product Information [Line Items]        
Percentage of management fee 10.00%      
Promissory note $ 5,000,000     $ 2,000,000
Debt interest per year 1.00% 1.00%    
Debt instrument maturity date Apr. 20, 2029 Apr. 20, 2029    
Pineapple Consolidated Inc [Member]        
Product Information [Line Items]        
Equity interest percentage     50.00%  
PNPL Holdings Inc [Member] | Revenue Benchmark [Member]        
Product Information [Line Items]        
Equity interest percentage     10.00%  
PNPLXpress X, Inc. [Member]        
Product Information [Line Items]        
Equity interest percentage     10.00%  
Goldstar Industrees [Member]        
Product Information [Line Items]        
Equity interest percentage     29.00%  
PNPLXpress, Inc. [Member]        
Product Information [Line Items]        
Equity interest percentage     10.00%  
PNPLXpress II, Inc. [Member]        
Product Information [Line Items]        
Equity interest percentage     49.00%  
Pineapple Equities, Inc. [Member]        
Product Information [Line Items]        
Equity interest percentage     24.00%  
5660 W. Pico & Hope [Member]        
Product Information [Line Items]        
Equity interest percentage     49.00%  
19841 Ventura & Hope [Member]        
Product Information [Line Items]        
Equity interest percentage     19.00%  
1485 W. Sunset & Hope [Member]        
Product Information [Line Items]        
Equity interest percentage     29.00%  
v3.24.4
GOING CONCERN (Details Narrative) - USD ($)
Oct. 31, 2024
Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accumulated deficit $ 924,146 $ 924,574
v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
 3 Months Ended
Oct. 31, 2024
shares
Property, Plant and Equipment [Line Items]  
Anti-dilutive, shares 0
Equipment and Software [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful life 1 year
Equipment and Software [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful life 5 years
Leasehold Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful life 1 year
v3.24.4
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
 3 Months Ended
Apr. 20, 2024
Apr. 30, 2024
Oct. 31, 2024
Related Party Transaction [Line Items]      
Related party transactions   $ 2,966,714  
Debt interest per year 1.00% 1.00%  
Debt instrument maturity date Apr. 20, 2029 Apr. 20, 2029  
Related Party [Member]      
Related Party Transaction [Line Items]      
Debt instrument face amount     $ 5,000,000
Long term debt     5 years
Debt obligation, reduced     $ 3,000,000
Pineapple Express Cannabis (PK) (USOTC:PNXP)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Pineapple Express Cannabis (PK) Charts.
Pineapple Express Cannabis (PK) (USOTC:PNXP)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Pineapple Express Cannabis (PK) Charts.